The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound

Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)

[search][options]

Editor

Personal info

View

About

Terms

Javascript disabled

Please enable Javascript support in your browser to use this application.

Instructions on how to enable JavaScript on different browsers can be found here: http://www.google.com/support/bin/answer.py?answer=23852.

Lisa Kurland

Department of Medical Sciences

Uppsala University Hospital

Uppsala

Sweden

[email]@medsci.uu.se

Name/email consistency: high

[Claim this account]

Affiliation

Department of Medical Sciences, Uppsala University Hospital, Uppsala, Sweden. 2001 - 2008

References

The relationship between the plasma concentration of irbesartan and the antihypertensive response is disclosed by an angiotensin II type 1 receptor polymorphism: results from the Swedish Irbesartan Left Ventricular Hypertrophy Investigation vs. Atenolol (SILVHIA) Trial. Kurland, L., Hallberg, P., Melhus, H., Liljedahl, U., Hashemi, N., Syvänen, A.C., Lind, L., Kahan, T. Am. J. Hypertens. (2008) [Pubmed]
Hypertension and SNP genotyping in antihypertensive treatment. Kurland, L., Liljedahl, U., Lind, L. Cardiovasc. Toxicol. (2005) [Pubmed]
Using genotyping to predict responses to anti-hypertensive treatment. Kurland, L., Lind, L., Melhus, H. Trends Pharmacol. Sci. (2005) [Pubmed]
Angiotensinogen gene polymorphisms: relationship to blood pressure response to antihypertensive treatment. Results from the Swedish Irbesartan Left Ventricular Hypertrophy Investigation vs Atenolol (SILVHIA) trial. Kurland, L., Liljedahl, U., Karlsson, J., Kahan, T., Malmqvist, K., Melhus, H., Syvänen, A.C., Lind, L. Am. J. Hypertens. (2004) [Pubmed]
The antihypertensive response to irbesartan treatment from a pharmacogenetic perspective. Kurland, L. Minerva Med. (2003) [Pubmed]
Polymorphisms in the angiotensinogen and angiotensin II type 1 receptor gene are related to change in left ventricular mass during antihypertensive treatment: results from the Swedish Irbesartan Left Ventricular Hypertrophy Investigation versus Atenolol (SILVHIA) trial. Kurland, L., Melhus, H., Karlsson, J., Kahan, T., Malmqvist, K., Ohman, P., Nyström, F., Hägg, A., Lind, L. J. Hypertens. (2002) [Pubmed]
Aldosterone synthase (CYP11B2) -344 C/T polymorphism is related to antihypertensive response: result from the Swedish Irbesartan Left Ventricular Hypertrophy Investigation versus Atenolol (SILVHIA) trial. Kurland, L., Melhus, H., Karlsson, J., Kahan, T., Malmqvist, K., Ohman, P., Nyström, F., Hägg, A., Lind, L. Am. J. Hypertens. (2002) [Pubmed]
Angiotensin converting enzyme gene polymorphism predicts blood pressure response to angiotensin II receptor type 1 antagonist treatment in hypertensive patients. Kurland, L., Melhus, H., Karlsson, J., Kahan, T., Malmqvist, K., Ohman, K.P., Nyström, F., Hägg, A., Lind, L. J. Hypertens. (2001) [Pubmed]